Advisory Council July 2017 Meeting Presentation: Clinical Services Subcommittee Federal Update

07/28/2017

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES

Friday, July 28, 2017

Printer Friendly Version in PDF Format (8 PDF pages)

 

Clinical Services Subcommittee Federal Update

Shari Ling, MD

New HRSA ADRD Professional Training Curriculum

  • Promotes interprofessional teamwork in the care of persons living with dementia (PLwD), to be used by health professions faculty, students, primary care practitioners, members of the interprofessional geriatrics care team, and direct service workers is now available
  • The 16 modules address a range of topics including dental care, emergency departments, pharmacy, ethics, stages of dementia, diversity -- and more!

Information at: https://bhw.hrsa.gov/grants/geriatrics/alzheimers-curriculum

ß Amyloid PET in Dementia and Neurodegenerative Disease Update

  • According to the Food and Drug Administration label for Amyvid™ (florbetapir F18), Neuraceq™ (florbetaben F18) and Vizamyl™ (flutemetamol F18), a positive scan does not establish a diagnosis of AD or other cognitive disorder; and
  • Safety and effectiveness of Amyvid have not been established for predicting development of dementia or other neurologic conditions; and monitoring responses to therapies
  • CMS determined that there is sufficient evidence that the use of PET Aß imaging is promising to:
    • exclude Alzheimer's disease (AD) in narrowly defined and clinically difficult differential diagnoses, such as AD versus frontotemporal dementia (FTD); and
    • enrich clinical trials seeking better treatments or prevention strategies for AD, by allowing for selection of patients on the basis of biological as well as clinical and epidemiological factors
  • In 2013, CMS published a National Coverage Decision to permit Medicare coverage for clinical studies to answer the following questions:
    • Do the results of PET Aß imaging lead to improved health outcomes? (Meaningful health outcomes of interest include: avoidance of futile treatment or tests; improving, or slowing the decline of, quality of life; and survival)
    • Are there specific subpopulations, patient characteristics or differential diagnoses that are predictive of improved health outcomes in patients whose management is guided by the PET Aß imaging?
    • Does using PET Aß imaging in guiding patient management, to enrich clinical trials seeking better treatments or prevention strategies for AD, by selecting patients on the basis of biological as well as clinical and epidemiological factors, lead to improved health outcomes?
  • Since publishing the NCD, several organizations have requested coverage for studies; approval is based on whether it is designed to answer at one of the questions, and whether the study adheres to CMS's published standards of scientific integrity and relevance to the Medicare population

To date, CMS has approved the following studies:

  • Cognitive Training and Practice Effects in MCI (University of Utah)
  • Imaging Dementia--Evidence for Amyloid Scanning (IDEAS) Study (American College of Radiology Imaging Network)
  • Effect of Aerobic Exercise on Pathophysiology in Preclinical Alzheimer's Disease (National Institute on Aging)
  • The largest of these studies, IDEAS, is enrolling more than 18,000 Medicare beneficiaries. Information about this study can be found here: http://www.ideas-study.org/

(Strategy 1.C)

Self-Direction of HCBS -- Training for Case Managers

  • Through self-direction, beneficiaries direct many or all of their own HCBS, including selecting and managing direct service workers and/or managing an individualized budget
  • CMS recently posted guidance through the Integrated Care Resource Center to assist case managers in managed care plans to guide beneficiaries
  • The curriculum provides tools to help case managers explain self-directed service delivery, and the related responsibilities of individuals choosing this option, as well as information for health plans about helping individuals to determine if the self-direction option is right for them
  • The guidance is also useful generally in educating beneficiaries, families, and caregivers in understanding self-directed service delivery

(Strategy 2.D)
Information at: http://www.integratedcareresourcecenter.com/integrationResourceLib/SDTraining.aspx

Home and Community-Based Settings Criteria Extension

  • In May CMS announced a three-year extension for state Medicaid programs to meet the Home and Community Based Services settings requirements for settings operating before March 17, 2014
  • The extension is in response to state requests for more time to demonstrate compliance with the regulatory requirements, and ensure compliance activities are collaborative, transparent, and timely

(Strategy 2.D)
Information at: https://www.medicaid.gov/medicaid/hcbs/guidance/index.html

The 2018 Physician Fee Schedule

  • CMS released a Notice of Proposed Rulemaking (NPRM) on July 13 (CMS 1676-P) to update payment policies, payment rates, and quality provisions for services furnished under the Medicare PFS on or after January 1, 2018
  • The PFS pays for services furnished by physicians and other practitioners in all sites of service to Medicare beneficiaries
  • This year's PFS includes a Request for Information for public feedback on positive solutions to better achieve transparency, flexibility, program simplification and innovation that will inform the discussion on future regulatory action related to the PFS

Comment at: https://www.federalregister.gov/public-inspection/current

Some 2018 PFS Proposals

  • Telehealth -- CMS is proposing to add several codes to the list of services eligible to be furnished via telehealth, including: HCPCS code G0296 (visit to determine low dose computed tomography eligibility), CPT code 90785 (Interactive Complexity), CPT codes 96160 and 96161 (Beneficiary and Caregiver Health Risk Assessment), HCPCS code G0506 (Care Planning for Chronic Care Management), and CPT codes 90839 and 90840 (Psychotherapy for Crisis); and to eliminate the required reporting of the GT modifier for professional claims in an effort to reduce provider administrative burden
  • New Care Coordination Services and Payment for Rural Health Clinics (RHCs) and Federally-Qualified Health Centers (FHQCs) - RHCs and FQHCs would receive payment for regular and complex CCM services, behavioral health integration services, and the psychiatric care coordination model using 2 new billing codes created exclusively for them, in addition to regular payment
  • Chronic Care Management - CMS is proposing to adopt CPT codes for reporting several chronic care management (CCM) services currently reported using Medicare G-codes, and seeking public comment on ways to further reduce burden on practitioners for CCM and similar services
  • Office-Based Behavioral Health Services - CMS is proposing an improvement in the way rates are set for office-based behavioral health services to increase payment for these services by better recognizing overhead expenses

(Strategy 2.G.)

Comprehensive Primary Care Plus (CPC+) Round 2 Region Announcement

  • CPC+ is an advanced primary care medical home model that rewards value and quality to support primary care practices to improve quality, access, and efficiency, and foster patient-centered care
  • The following four regions were selected for CPC+ Round 2 in May: Louisiana, Nebraska, North Dakota, and New York (Erie/Niagara Counties)
  • "Track 2" of the demonstration is for practices proficient in primary care that can increase the depth, breadth, and scope of medical care delivered to complex patients, including people with dementia, with a $100/month per beneficiary per month care management fee

(Strategy 2E)
Information at: https://innovation.cms.gov/initiatives/comprehensive-primary-care-plus

Behavioral Health Model Opportunity

  • CMS is having a one day in-person Summit to discuss potential behavioral health payment and care delivery models on September 8, 2017 in Baltimore
  • The Summit will provide valuable public discussion and ideas to explore potential payment model and care delivery options in the future
  • The following topics are under consideration:
    • Substance use disorders
    • Mental health and medical comorbidities
    • Alzheimer's disease and related dementias
    • Behavioral health workforce challenges

(Strategy 2E)
Information at: https://innovation.cms.gov/resources/behavioral-health-paymentcare-summit.html

Arbitration in Long-Term Care Facilities

  • In June CMS issued a Notice of Proposed Rulemaking (NPRM) to improve the nursing home arbitration process
  • The NPRM removes a prohibition on pre-dispute binding arbitration agreements; requires agreements be in plain language; and makes other changes to the arbitration process included in last year's Final Long-Term Care Rule
  • The comment period closes on August 7, 2017

(Strategy 2F)
Information at: https://www.federalregister.gov/public-inspection/current

Money Follows the Person Annual Report

  • In May CMS released the Money Follows the Person (MFP) Annual Report
  • The 11,661 transitions during 2015 marked the largest annual number transitioned
  • The national evaluation for the first time has estimated cost savings associated with transitions from institution to community
  • Consistently MFP participants have reported significant improvement in the quality of their lives in the community

(Strategy 2G)
Information at: https://www.medicaid.gov/medicaid/ltss/downloads/money-follows-the-person/mfp-2015-annual-report.pdf

National Partnership to Improve Dementia Care in Nursing Homes

  • The June 15 Medicare Learning Network (MLN) Connects® call on the National Partnership to Improve Dementia Care and Quality Assurance and Performance Improvement focused on appropriate assessment and evaluation for the accurate diagnosis of schizophrenia and other mental disorders, and the work of CMS's Quality Innovation Network-Quality Improvement Organizations

(Strategy 3.D)
Information at: https://www.cms.gov/Outreach-and-Education/Outreach/NPC/National-Provider-Calls-and-Events-Items/2017-06-15-Dementia-Care.html?DLPage=1&DLEntries=10&DLFilter=dementia&DLSort=0&DLSortDir=descending

QUESTIONS?

Shari Ling
shari.ling@cms.hhs.gov


July 28, 2017 -- Advisory Council Meeting #25

The meeting was held on Friday, January 26, 2018, in Washington, DC. The Research Subcommittee took charge of this meeting's theme, focusing on the process from targets to treatments. The Council heard speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting also included discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates. Material available from this meeting is listed below and is also available at https://aspe.hhs.gov/advisory-council-alzheimers-research-care-and-services-meetings#Jan2018.

Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.


 

General Information

 

Presentation Slides

 

Videos

  • Welcome thru Clinical Care -- [Video]

  • LTSS Research -- [Video]

  • Public Comments thru Federal Workgroup Updates -- [Video]

  • Recommendations thru Adjourn -- [Video]


Return to

National Alzheimer's Project Act Home Page

Advisory Council on Alzheimer's Research, Care, and Services Page

Advisory Council on Alzheimer's Research, Care, and Services Meetings Page